Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 480

1.

Vena Cava Filters and In-Hospital Case Fatality Among Patients With Pulmonary Embolism: Results From a Large Population-Based Study.

Pomero F, Ageno W, Dentali F, Fenoglio L, Squizzato A, Bonzini M.

Clin Appl Thromb Hemost. 2019 Jan-Dec;25:1076029619888022. doi: 10.1177/1076029619888022.

PMID:
31746216
2.

Validation and psychometric properties of the Maltese version of the Duke Anticoagulation Satisfaction Scale (DASS).

Riva N, Borg Xuereb C, Ageno W, Makris M, Gatt A.

Psychol Res Behav Manag. 2019 Aug 28;12:741-752. doi: 10.2147/PRBM.S216617. eCollection 2019.

3.

Splanchnic Vein Thrombosis: Current Perspectives.

Valeriani E, Riva N, Di Nisio M, Ageno W.

Vasc Health Risk Manag. 2019 Oct 22;15:449-461. doi: 10.2147/VHRM.S197732. eCollection 2019. Review.

4.

D-dimer testing, with gender-specific cutoff levels, is of value to assess the individual risk of venous thromboembolic recurrence in non-elderly patients of both genders: a post hoc analysis of the DULCIS study.

Palareti G, Legnani C, Antonucci E, Cosmi B, Poli D, Testa S, Tosetto A, Ageno W, Falanga A, Ferrini PM, Pengo V, Prandoni P; DULCIS (D-dimer and ULtrasonography in Combination Italian Study) Investigators.

Intern Emerg Med. 2019 Nov 5. doi: 10.1007/s11739-019-02216-y. [Epub ahead of print]

PMID:
31691119
5.

The risk of post-thrombotic syndrome in patients with proximal deep vein thrombosis treated with the direct oral anticoagulants.

Prandoni P, Ageno W, Ciammaichella M, Mumoli N, Zanatta N, Imberti D, Visonà A, Bucherini E, Di Nisio M, Noventa F; DOAC-PTS Investigators.

Intern Emerg Med. 2019 Oct 30. doi: 10.1007/s11739-019-02215-z. [Epub ahead of print]

PMID:
31667697
6.

Trends in mortality related to pulmonary embolism in the European Region, 2000-15: analysis of vital registration data from the WHO Mortality Database.

Barco S, Mahmoudpour SH, Valerio L, Klok FA, Münzel T, Middeldorp S, Ageno W, Cohen AT, Hunt BJ, Konstantinides SV.

Lancet Respir Med. 2019 Oct 11. pii: S2213-2600(19)30354-6. doi: 10.1016/S2213-2600(19)30354-6. [Epub ahead of print]

PMID:
31615719
7.

Very elderly patients with venous thromboembolism on oral anticoagulation with VKAs or DOACs: Results from the prospective multicenter START2-Register Study.

Poli D, Antonucci E, Bertù L, Vignini E, Ruocco L, Mastroiacovo D, Paparo C, Pastori D, Testa S, Ageno W, Palareti G; coordinator of START2 Register.

Thromb Res. 2019 Nov;183:28-32. doi: 10.1016/j.thromres.2019.08.024. Epub 2019 Aug 26.

8.

Extended prophylaxis of venous thromboembolism with betrixaban in acutely ill medical patients with and without cancer: insights from the APEX trial.

Ageno W, Lopes RD, Yee MK, Hernandez A, Hull R, Goldhaber SZ, Gibson CM, Cohen AT.

J Thromb Thrombolysis. 2020 Feb;49(2):214-219. doi: 10.1007/s11239-019-01943-5.

PMID:
31493287
9.

Reliability and validity of the Maltese version of the Perception of Anticoagulant Treatment Questionnaire (PACT-Q).

Riva N, Borg Xuereb C, Makris M, Ageno W, Gatt A.

Patient Prefer Adherence. 2019 Jun 19;13:969-979. doi: 10.2147/PPA.S207498. eCollection 2019.

10.

Net-clinical benefit of extended prophylaxis of venous thromboembolism with betrixaban in medically ill patients aged 80 or more.

Ageno W, Lopes RD, Yee MK, Hernandez A, Hull RD, Goldhaber SZ, Gibson CM, Cohen AT.

J Thromb Haemost. 2019 Dec;17(12):2089-2098. doi: 10.1111/jth.14600. Epub 2019 Aug 26.

PMID:
31392827
11.

Isolated Distal Deep Vein Thrombosis: Perspectives from the GARFIELD-VTE Registry.

Schellong SM, Goldhaber SZ, Weitz JI, Ageno W, Bounameaux H, Turpie AGG, Angchaisuksiri P, Haas S, Goto S, Zaghdoun A, Farjat A, Nielsen JD, Kayani G, Mantovani LG, Prandoni P, Kakkar AK.

Thromb Haemost. 2019 Oct;19(10):1675-1685. doi: 10.1055/s-0039-1693461. Epub 2019 Aug 1.

12.

D-dimer levels during and after anticoagulation withdrawal in patients with venous thromboembolism treated with non-vitamin K anticoagulants.

Legnani C, Martinelli I, Palareti G, Ciavarella A, Poli D, Ageno W, Testa S, Mastroiacovo D, Ciammaichella M, Bucherini E, Mumoli N, Cosmi B.

PLoS One. 2019 Jul 16;14(7):e0219751. doi: 10.1371/journal.pone.0219751. eCollection 2019.

13.

A survey on the views and attitudes of Italian physicians with regards to venous thromboembolism prophylaxis and treatment.

Ageno W, Di Minno G, Agnelli G, Cimminiello C, Imberti D, Polo Friz H, Prandoni P, Scaglione F.

Minerva Med. 2019 Jul 9. doi: 10.23736/S0026-4806.19.06034-8. [Epub ahead of print] No abstract available.

PMID:
31295981
14.

Patient Management Strategies and Long-Term Outcomes in Isolated Distal Deep-Vein Thrombosis versus Proximal Deep-Vein Thrombosis: Findings from XALIA.

Ageno W, Mantovani LG, Haas S, Kreutz R, Monje D, Schneider J, Bugge JP, Gebel M, Turpie AGG.

TH Open. 2019 Mar 26;3(1):e85-e93. doi: 10.1055/s-0039-1683968. eCollection 2019 Jan.

15.

Causes and Risk Factors of Cerebral Ischemic Events in Patients With Atrial Fibrillation Treated With Non-Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention.

Paciaroni M, Agnelli G, Caso V, Silvestrelli G, Seiffge DJ, Engelter S, De Marchis GM, Polymeris A, Zedde ML, Yaghi S, Michel P, Eskandari A, Antonenko K, Sohn SI, Cappellari M, Tassinari T, Tassi R, Masotti L, Katsanos AH, Giannopoulos S, Acciarresi M, Alberti A, Venti M, Mosconi MG, Vedovati MC, Pierini P, Giustozzi M, Lotti EM, Ntaios G, Kargiotis O, Monaco S, Lochner P, Bandini F, Liantinioti C, Palaiodimou L, Abdul-Rahim AH, Lees K, Mancuso M, Pantoni L, Rosa S, Bertora P, Galliazzo S, Ageno W, Toso E, Angelini F, Chiti A, Orlandi G, Denti L, Flomin Y, Marcheselli S, Mumoli N, Rimoldi A, Verrengia E, Schirinzi E, Del Sette M, Papamichalis P, Komnos A, Popovic N, Zarkov M, Rocco A, Diomedi M, Giorli E, Ciccone A, Mac Grory BC, Furie KL, Bonetti B, Saia V, Guideri F, Acampa M, Martini G, Grifoni E, Padroni M, Karagkiozi E, Perlepe K, Makaritsis K, Mannino M, Maccarrone M, Ulivi L, Giannini N, Ferrari E, Pezzini A, Doronin B, Volodina V, Baldi A, D'Amore C, Deleu D, Corea F, Putaala J, Santalucia P, Nardi K, Risitano A, Toni D, Tsivgoulis G.

Stroke. 2019 Aug;50(8):2168-2174. doi: 10.1161/STROKEAHA.119.025350. Epub 2019 Jun 25.

PMID:
31234756
16.

Anticoagulation After Stroke in Patients With Atrial Fibrillation.

Altavilla R, Caso V, Bandini F, Agnelli G, Tsivgoulis G, Yaghi S, Furie KL, Tadi P, Becattini C, Zedde M, Abdul-Rahim AH, Lees KR, Alberti A, Venti M, Acciarresi M, D'Amore C, Mosconi MG, Anna Cimini L, Fusaro J, Bovi P, Carletti M, Rigatelli A, Cappellari M, Putaala J, Tomppo L, Tatlisumak T, Marcheselli S, Pezzini A, Poli L, Padovani A, Masotti L, Vannucchi V, Sohn SI, Lorenzini G, Tassi R, Guideri F, Acampa M, Martini G, Ntaios G, Athanasakis G, Makaritsis K, Karagkiozi E, Vadikolias K, Liantinioti C, Chondrogianni M, Mumoli N, Consoli D, Galati F, Sacco S, Carolei A, Tiseo C, Corea F, Ageno W, Bellesini M, Silvestrelli G, Ciccone A, Lanari A, Scoditti U, Denti L, Mancuso M, Maccarrone M, Ulivi L, Orlandi G, Giannini N, Gialdini G, Tassinari T, De Lodovici ML, Bono G, Rueckert C, Baldi A, D'Anna S, Toni D, Letteri F, Giuntini M, Maria Lotti E, Flomin Y, Pieroni A, Kargiotis O, Karapanayiotides T, Monaco S, Maimone Baronello M, Csiba L, Szabó L, Chiti A, Giorli E, Del Sette M, Imberti D, Zabzuni D, Doronin B, Volodina V, Michel P, Vanacker P, Barlinn K, Pallesen LP, Barlinn J, Deleu D, Melikyan G, Ibrahim F, Akhtar N, Gourbali V, Paciaroni M.

Stroke. 2019 Aug;50(8):2093-2100. doi: 10.1161/STROKEAHA.118.022856. Epub 2019 Jun 21.

PMID:
31221054
17.

Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD-VTE patients.

Haas S, Ageno W, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Dalsgaard Nielsen J, Kayani G, Zaghdoun A, Farjat AE, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK.

J Thromb Haemost. 2019 Oct;17(10):1694-1706. doi: 10.1111/jth.14548. Epub 2019 Jul 23.

PMID:
31220403
18.

Upper Extremity DVT versus Lower Extremity DVT: Perspectives from the GARFIELD-VTE Registry.

Ageno W, Haas S, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Dalsgaard Nielsen J, Kayani G, Farjat AE, Zaghdoun A, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Darius H, Kakkar AK.

Thromb Haemost. 2019 Aug;119(8):1365-1372. doi: 10.1055/s-0039-1688828. Epub 2019 Jun 10.

PMID:
31183844
19.

Epidemiology and secondary prevention of ischemic stroke in patients on antiplatelet drug: a retrospective cohort study.

Gallo A, Galliazzo S, Grazioli S, Guasti L, Ageno W, Squizzato A.

J Thromb Thrombolysis. 2019 Aug;48(2):336-344. doi: 10.1007/s11239-019-01893-y.

PMID:
31177486
20.

Early recurrence in paroxysmal versus sustained atrial fibrillation in patients with acute ischaemic stroke.

Paciaroni M, Angelini F, Agnelli G, Tsivgoulis G, Furie KL, Tadi P, Becattini C, Falocci N, Zedde M, Abdul-Rahim AH, Lees KR, Alberti A, Venti M, Acciarresi M, Altavilla R, D'Amore C, Mosconi MG, Cimini LA, Bovi P, Carletti M, Rigatelli A, Cappellari M, Putaala J, Tomppo L, Tatlisumak T, Bandini F, Marcheselli S, Pezzini A, Poli L, Padovani A, Masotti L, Vannucchi V, Sohn SI, Lorenzini G, Tassi R, Guideri F, Acampa M, Martini G, Ntaios G, Karagkiozi E, Athanasakis G, Makaritsis K, Vadikolias K, Liantinioti C, Chondrogianni M, Mumoli N, Consoli D, Galati F, Sacco S, Carolei A, Tiseo C, Corea F, Ageno W, Bellesini M, Silvestrelli G, Ciccone A, Scoditti U, Denti L, Mancuso M, Maccarrone M, Orlandi G, Giannini N, Gialdini G, Tassinari T, Lodovici ML, Bono G, Rueckert C, Baldi A, Toni D, Letteri F, Giuntini M, Lotti EM, Flomin Y, Pieroni A, Kargiotis O, Karapanayiotides T, Monaco S, Baronello MM, Csiba L, Szabó L, Chiti A, Giorli E, Sette MD, Imberti D, Zabzuni D, Doronin B, Volodina V, Michel Pd-Mer P, Vanacker P, Barlinn K, Pallesen LP, Kepplinger J, Deleu D, Melikyan G, Ibrahim F, Akhtar N, Gourbali V, Yaghi S, Caso V.

Eur Stroke J. 2019 Mar;4(1):55-64. doi: 10.1177/2396987318785853. Epub 2018 Jul 25.

21.

Oral anticoagulation in very elderly patients with atrial fibrillation: Results from the prospective multicenter START2-REGISTER study.

Poli D, Antonucci E, Ageno W, Bertù L, Migliaccio L, Martinese L, Pilato G, Testa S, Palareti G.

PLoS One. 2019 May 23;14(5):e0216831. doi: 10.1371/journal.pone.0216831. eCollection 2019.

22.

Early discharge and home treatment of patients with low-risk pulmonary embolism with the oral factor Xa inhibitor rivaroxaban: an international multicentre single-arm clinical trial.

Barco S, Schmidtmann I, Ageno W, Bauersachs RM, Becattini C, Bernardi E, Beyer-Westendorf J, Bonacchini L, Brachmann J, Christ M, Czihal M, Duerschmied D, Empen K, Espinola-Klein C, Ficker JH, Fonseca C, Genth-Zotz S, Jiménez D, Harjola VP, Held M, Iogna Prat L, Lange TJ, Manolis A, Meyer A, Mustonen P, Rauch-Kroehnert U, Ruiz-Artacho P, Schellong S, Schwaiblmair M, Stahrenberg R, Westerweel PE, Wild PS, Konstantinides SV, Lankeit M; HoT-PE Investigators .

Eur Heart J. 2020 Jan 21;41(4):509-518. doi: 10.1093/eurheartj/ehz367.

PMID:
31120118
23.

Treatment of venous thromboembolism with tinzaparin in oncological patients.

Ageno W, Barni S, Di Nisio M, Falanga A, Imberti D, Labianca RF, Mantovani L.

Minerva Med. 2019 Jun;110(3):251-258. doi: 10.23736/S0026-4806.19.06026-9. Review.

24.

Portal Vein Thrombosis in Decompensated Cirrhosis: Rationale for Treatment.

Senzolo M, Riva N, Dentali F, Sartori MT, Ageno W; IRSVT Study Investigators.

Clin Transl Gastroenterol. 2019 Apr;10(4):e00026. doi: 10.14309/ctg.0000000000000026. No abstract available.

25.

The management of anticoagulant treatment in non-valvular atrial fibrillation real-world patients.

Valeriani E, Ageno W.

Eur J Intern Med. 2019 Apr;62:7-8. doi: 10.1016/j.ejim.2019.03.012. Epub 2019 Mar 25. No abstract available.

PMID:
30922658
26.

XALIA-LEA: An observational study of venous thromboembolism treatment with rivaroxaban and standard anticoagulation in the Asia-Pacific, Eastern Europe, the Middle East, Africa and Latin America.

Kreutz R, Mantovani LG, Haas S, Monje D, Schneider J, Bugge JP, Gebel M, Tamm M, Ageno W, Turpie AGG.

Thromb Res. 2019 Apr;176:125-132. doi: 10.1016/j.thromres.2019.02.010. Epub 2019 Feb 13.

27.

Position paper on laboratory testing for patients with haemophilia. A consensus document from SISET, AICE, SIBioC and SIPMeL.

Tripodi A, Santoro RC, Testa S, Molinari AC, Bernardini S, Golato M, Lippi G, Ageno W, Santagostino E.

Blood Transfus. 2019 May;17(3):229-236. doi: 10.2450/2019.0241-18. Epub 2019 Feb 4. Review. No abstract available.

28.

Accuracy of age-adjusted D-dimer to rule out deep vein thrombosis in the elderly.

Riva N, Righini M, Camporese G, Iotti M, Bucherini E, Kamphuisen PW, Verhamme P, Douketis JD, Tonello C, Prandoni P, Ageno W; PALLADIO Study Investigators.

Thromb Res. 2019 Feb;174:148-150. doi: 10.1016/j.thromres.2018.12.024. Epub 2019 Jan 3. No abstract available.

PMID:
30634165
29.

The Non-Vitamin K Antagonist Oral Anticoagulants in Heart Disease: Section V-Special Situations.

De Caterina R, Ageno W, Agnelli G, Chan NC, Diener HC, Hylek E, Raskob GE, Siegal DM, Verheugt FWA, Lip GYH, Weitz JI.

Thromb Haemost. 2019 Jan;119(1):14-38. doi: 10.1055/s-0038-1675816. Epub 2018 Dec 31. Review.

PMID:
30597497
30.

Intracranial bleeding risk after minor traumatic brain injury in patients on antithrombotic drugs.

Galliazzo S, Bianchi MD, Virano A, Trucchi A, Donadini MP, Dentali F, Bertù L, Grandi AM, Ageno W.

Thromb Res. 2019 Feb;174:113-120. doi: 10.1016/j.thromres.2018.12.015. Epub 2018 Dec 12.

PMID:
30593997
31.

Characteristics and Management of Patients with Venous Thromboembolism: The GARFIELD-VTE Registry.

Ageno W, Haas S, Weitz JI, Goldhaber SZ, Turpie AGG, Goto S, Angchaisuksiri P, Nielsen JD, Kayani G, Pieper KS, Schellong S, Bounameaux H, Mantovani LG, Prandoni P, Kakkar AK; GARFIELD-VTE investigators.

Thromb Haemost. 2019 Feb;119(2):319-327. doi: 10.1055/s-0038-1676611. Epub 2018 Dec 28.

PMID:
30593086
32.

Hemorrhagic Transformation in Patients With Acute Ischemic Stroke and Atrial Fibrillation: Time to Initiation of Oral Anticoagulant Therapy and Outcomes.

Paciaroni M, Bandini F, Agnelli G, Tsivgoulis G, Yaghi S, Furie KL, Tadi P, Becattini C, Zedde M, Abdul-Rahim AH, Lees KR, Alberti A, Venti M, Acciarresi M, D'Amore C, Mosconi MG, Cimini LA, Altavilla R, Volpi G, Bovi P, Carletti M, Rigatelli A, Cappellari M, Putaala J, Tomppo L, Tatlisumak T, Marcheselli S, Pezzini A, Poli L, Padovani A, Masotti L, Vannucchi V, Sohn SI, Lorenzini G, Tassi R, Guideri F, Acampa M, Martini G, Ntaios G, Athanasakis G, Makaritsis K, Karagkiozi E, Vadikolias K, Liantinioti C, Chondrogianni M, Mumoli N, Consoli D, Galati F, Sacco S, Carolei A, Tiseo C, Corea F, Ageno W, Bellesini M, Colombo G, Silvestrelli G, Ciccone A, Lanari A, Scoditti U, Denti L, Mancuso M, Maccarrone M, Ulivi L, Orlandi G, Giannini N, Gialdini G, Tassinari T, De Lodovici ML, Bono G, Rueckert C, Baldi A, D'Anna S, Toni D, Letteri F, Giuntini M, Lotti EM, Flomin Y, Pieroni A, Kargiotis O, Karapanayiotides T, Monaco S, Maimone Baronello M, Csiba L, Szabó L, Chiti A, Giorli E, Del Sette M, Imberti D, Zabzuni D, Doronin B, Volodina V, Michel P, Vanacker P, Barlinn K, Pallesen LP, Barlinn J, Deleu D, Melikyan G, Ibrahim F, Akhtar N, Gourbali V, Caso V.

J Am Heart Assoc. 2018 Nov 20;7(22):e010133. doi: 10.1161/JAHA.118.010133.

33.

Breadth of complications of long-term oral anticoagulant care.

Ageno W, Donadini M.

Hematology Am Soc Hematol Educ Program. 2018 Nov 30;2018(1):432-438. doi: 10.1182/asheducation-2018.1.432. Review.

34.

XXV Congresso Nazionale della Società Italiana per lo Studio dell'Emostasi e della Trombosi (SISET).

Ageno W, Falanga A, Castaman G.

Blood Transfus. 2018 Nov 7;16(Supplement no. 4):s415-s562. doi: 10.2450/2018.S4. [Epub ahead of print] No abstract available.

35.

Healthcare resource use in XALIA: A subgroup analysis of a non-interventional study of rivaroxaban versus standard anticoagulation for deep vein thrombosis.

Mantovani LG, Haas S, Kreutz R, Folkerts K, Gebel M, Monje D, Schneider J, van Eickels M, Sahin K, Zell E, Ageno W, Turpie AGG.

Eur J Intern Med. 2019 Mar;61:29-33. doi: 10.1016/j.ejim.2018.10.002. Epub 2018 Oct 19.

36.

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism: reply.

Palareti G, Antonucci E, Ageno W, Mastroiacovo D, Poli D, Tosetto A.

J Thromb Haemost. 2018 Dec;16(12):2539-2540. doi: 10.1111/jth.14300. Epub 2018 Oct 15. No abstract available.

PMID:
30240521
37.

Ultrasound elastography is useful to distinguish acute and chronic deep vein thrombosis.

Mumoli N, Mastroiacovo D, Giorgi-Pierfranceschi M, Pesavento R, Mochi M, Cei M, Pomero F, Mazzone A, Vitale J, Ageno W, Dentali F.

J Thromb Haemost. 2018 Dec;16(12):2482-2491. doi: 10.1111/jth.14297. Epub 2018 Oct 12.

PMID:
30225971
38.

Risk of bleeding and arterial cardiovascular events in patients with splanchnic vein thrombosis in Denmark: a population-based cohort study.

Søgaard KK, Adelborg K, Darvalics B, Horváth-Puhó E, Beyer-Westendorf J, Ageno W, Sørensen HT.

Lancet Haematol. 2018 Oct;5(10):e441-e449. doi: 10.1016/S2352-3026(18)30133-9. Epub 2018 Sep 7.

PMID:
30201587
39.

Rivaroxaban for Thromboprophylaxis after Hospitalization for Medical Illness.

Spyropoulos AC, Ageno W, Albers GW, Elliott CG, Halperin JL, Hiatt WR, Maynard GA, Steg PG, Weitz JI, Suh E, Spiro TE, Barnathan ES, Raskob GE; MARINER Investigators.

N Engl J Med. 2018 Sep 20;379(12):1118-1127. doi: 10.1056/NEJMoa1805090. Epub 2018 Aug 26.

40.

Predictive value of venous thromboembolism (VTE)-BLEED to predict major bleeding and other adverse events in a practice-based cohort of patients with VTE: results of the XALIA study.

Klok FA, Barco S, Turpie AGG, Haas S, Kreutz R, Mantovani LG, Gebel M, Herpers M, Bugge JP, Kostantinides SV, Ageno W.

Br J Haematol. 2018 Nov;183(3):457-465. doi: 10.1111/bjh.15533. Epub 2018 Aug 19.

41.

Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis.

Senzolo M, Riva N, Dentali F, Rodriguez-Castro K, Sartori MT, Bang SM, Martinelli I, Schulman S, Alatri A, Beyer-Westendorf J, Di Minno MND, Ageno W; IRSVT study investigators.

Clin Transl Gastroenterol. 2018 Aug 15;9(8):176. doi: 10.1038/s41424-018-0043-2.

42.

Biomarkers for the diagnosis of venous thromboembolism: D-dimer, thrombin generation, procoagulant phospholipid and soluble P-selectin.

Riva N, Vella K, Hickey K, Bertù L, Zammit D, Spiteri S, Kitchen S, Makris M, Ageno W, Gatt A.

J Clin Pathol. 2018 Nov;71(11):1015-1022. doi: 10.1136/jclinpath-2018-205293. Epub 2018 Aug 9.

PMID:
30093507
43.

Antithrombotic therapy for patients with an indication for oral anticoagulation undergoing percutaneous coronary intervention with stent: The case of venous thromboembolism.

Riva L, Ageno W, Di Pasquale G, Agnelli G, Rubboli A.

Int J Cardiol. 2018 Oct 15;269:75-79. doi: 10.1016/j.ijcard.2018.07.133. Epub 2018 Jul 26. Review.

PMID:
30060974
44.

The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism.

Palareti G, Antonucci E, Mastroiacovo D, Ageno W, Pengo V, Poli D, Testa S, Tosetto A, Prandoni P.

J Thromb Haemost. 2018 Oct;16(10):1994-2002. doi: 10.1111/jth.14253. Epub 2018 Aug 24.

PMID:
30059189
45.

Residual vein obstruction in patients diagnosed with acute isolated distal deep vein thrombosis associated with active cancer.

Dentali F, Barco S, Pegoraro S, Di Minno MND, Mastroiacovo D, Pomero F, Lodigiani C, Bagna F, Sartori M, Barillari G, Mumoli N, Napolitano M, Passamonti SM, Benedetti R, Ageno W, Di Nisio M.

J Thromb Thrombolysis. 2018 Oct;46(3):404-408. doi: 10.1007/s11239-018-1708-0.

PMID:
30014299
46.

Reducing the burden of venous thromboembolism in the acute medically ill population with extended-duration thromboprophylaxis.

Ageno W, Hunt BJ.

Eur Heart J Suppl. 2018 May;20(Suppl E):E6-E11. doi: 10.1093/eurheartj/suy015. Epub 2018 May 9.

47.

Antithrombotic therapy for venous thromboembolism in patients with cancer: expert guidance.

Imberti D, Cimminiello C, Di Nisio M, Marietta M, Polo Friz H, Ageno W.

Expert Opin Pharmacother. 2018 Aug;19(11):1177-1185. doi: 10.1080/14656566.2018.1496238. Epub 2018 Jul 16. Review.

PMID:
29963962
48.

Abnormal vaginal bleeding in women of reproductive age treated with edoxaban or warfarin for venous thromboembolism: a post hoc analysis of the Hokusai-VTE study.

Scheres L, Brekelmans M, Ageno W, Ay C, Büller HR, Eichinger S, Hutten BA, Klok FA, Middeldorp S, Schreiber K, Stach K, Blondon M, Delluc A.

BJOG. 2018 Nov;125(12):1581-1589. doi: 10.1111/1471-0528.15388. Epub 2018 Jul 20.

49.

Initial and Long-Term Treatment of Pulmonary Embolism: Current Approach and Future Perspectives.

Donadini MP, Ageno W.

Hamostaseologie. 2018 May;38(2):75-86. doi: 10.1055/s-0038-1641605. Epub 2018 May 29. Review.

PMID:
29843172
50.

Estimating renal function in patients with atrial fibrillation: which dose of direct oral anticoagulants?

Riva N, Ageno W, Gatt A.

Intern Emerg Med. 2018 Oct;13(7):1001-1004. doi: 10.1007/s11739-018-1883-1. Epub 2018 May 24. No abstract available.

PMID:
29797287

Supplemental Content

Support Center